Funakoshi S, Tamamura H, Ohta M, Yoshizawa K, Funakoshi A, Miyasaka K, Tateishi K, Tatemoto K, Nakano I, Yajima H
Faculty of Pharmaceutical Sciences, Kyoto University, Japan.
Biochem Biophys Res Commun. 1989 Oct 16;164(1):141-8. doi: 10.1016/0006-291x(89)91694-x.
A protein with pancreastatin-like immunoreactivity has been isolated and purified from liver metastasis of a patient with insulinoma. NH2-terminal sequence analysis in conjunction with the use of antibodies specific for the C-terminal structure of pancreastatin identified this protein as a 186-amino acid residue protein corresponding to human chromogranin A-116-301. Using a sensitive radioimmunoassay it was found that serum from the patient with insulinoma contains two peptide species; one comigrates with the 186-amino acid residue pancreastatin and the other the 48-residue pancreastatin.
从一名胰岛素瘤患者的肝转移灶中分离并纯化出一种具有胰抑制素样免疫反应性的蛋白质。通过氨基末端序列分析,并结合使用针对胰抑制素C末端结构的特异性抗体,确定该蛋白质为一种含有186个氨基酸残基的蛋白质,对应于人嗜铬粒蛋白A-116-301。使用灵敏的放射免疫分析法发现,胰岛素瘤患者的血清中含有两种肽类物质;一种与含有186个氨基酸残基的胰抑制素迁移率相同,另一种与含有48个残基的胰抑制素迁移率相同。